(Circulation. 2001;103:1115.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Physiology (X.-L.N., X.Y., K.H., H.N.) and Microbiology (K.T., S.S., Y.K.), School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Correspondence to Prof H. Nakazawa, Department of Physiology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193 Japan. E-mail: nakazawa{at}is.icc.u-tokai.ac.jp
BackgroundAlthough endothelial nitric oxide synthase (NOS) is antiatherogenic, the role of inducible NOS (iNOS) in the development of atherosclerosis is not established.
Methods and ResultsWe compared the susceptibility of iNOS knockout (iNOS-/-) and wild-type (iNOS+/+) mice to the development of atherosclerosis induced by feeding an atherogenic diet for 15 weeks. Plasma lipid level, atherosclerotic lesion size, and cellular density in the lesions were all similar in the 2 strains (lesion size: iNOS+/+ 285±73x103 µm2, iNOS-/- 293±82x103 µm2, n=10). iNOS mRNA was detected in the lesions of iNOS+/+ but not iNOS-/- mice through RT-PCR. Immunohistochemically, iNOS+/+ mice showed iNOS staining in macrophages and medial smooth muscle cells in the lesions. Nitrotyrosine staining showed a similar distribution, whereas it was absent in iNOS-/- mice. There was no apparent difference in the intensity or distribution of vascular cell adhesion molecule-1 staining in the lesions of the 2 strains. However, the lesions of iNOS+/+ mice showed a markedly decreased extracellular collagen content compared with those of iNOS-/- mice
ConclusionsiNOS induction does not affect the development of atherosclerosis in mice fed an atherogenic diet, but the resulting lesions show decreased levels of extracellular collagen and may be more fragile.
Key Words: mice, inbred atherosclerosis nitric oxide synthase
This article has been cited by other articles:
![]() |
J. Tanaka, L. Qiang, A. S. Banks, C. L. Welch, M. Matsumoto, T. Kitamura, Y. Ido-Kitamura, R. A. DePinho, and D. Accili Foxo1 Links Hyperglycemia to LDL Oxidation and Endothelial Nitric Oxide Synthase Dysfunction in Vascular Endothelial Cells Diabetes, October 1, 2009; 58(10): 2344 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mayr, Y. Zou, Z. Zhang, H. Dietrich, Y. Hu, and Q. Xu Accelerated Arteriosclerosis of Vein Grafts in Inducible NO Synthase-/- Mice Is Related to Decreased Endothelial Progenitor Cell Repair Circ. Res., February 17, 2006; 98(3): 412 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Feinberg, M. Watanabe, M. A. Lebedeva, A. S. Depina, J.-i. Hanai, T. Mammoto, J. P. Frederick, X.-F. Wang, V. P. Sukhatme, and M. K. Jain Transforming Growth Factor-{beta}1 Inhibition of Vascular Smooth Muscle Cell Activation Is Mediated via Smad3 J. Biol. Chem., April 16, 2004; 279(16): 16388 - 16393. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G Ferrini, H. H Davila, E. G.A Valente, N. F Gonzalez-Cadavid, and J. Rajfer Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media Cardiovasc Res, March 1, 2004; 61(4): 796 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bea, E. Blessing, B. J Bennett, C. C. Kuo, L. A. Campbell, J. Kreuzer, and M. E Rosenfeld Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis Cardiovasc Res, October 15, 2003; 60(1): 198 - 204. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |